Rachit is a senior associate contributing to the health assurance team through driving success in our portfolio and our new investments. He is based in San Francisco. 

He's been instrumental in our seed investment in Pallando Therapeutics and as a key contributor on our seed investment in Prox Bio, growth investment in FogPharma and GC's first biotech IPO follow-on, ArriVent. Before GC, he was a healthcare analyst at Caas Capital Management, where he helped establish the biotech strategy for private and public markets.

Rachit completed his bachelor's in biology at Bard College and his PhD in biology at MIT. There, he also earned a healthcare certificate from the Sloan School of Management.